This website uses cookies to enhance the user experience.
D

DAIICHI SANKYO NORDICS APS - NORWAY FILIAL920 777 457

Research
Norwegian division of foreign business enterprise
Amagerfaelledvej 106, 2. sal 2300 Kobenhavn S Kobenhavn, Danmark
Services
/ Research
/ 72.110 Research and experimental development on biotechnology

DAIICHI SANKYO NORDICS APS - NORWAY FILIAL

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO
ÅM

Åke Magnus Gisel1977

Years since formation
7 years
since May 3, 2018
Type
Norwegian division of foreign business enterprise
VAT registered
No
Number of employees
0

Financials

Total operating income 2024
8,583,627
NOK
Annual total result 2024
1,293,454
NOK
Total equity 2024
1,938,954
NOK
Last update: Feb 1, 2025

Management

Management / administration

NameRoleShares
ÅM

Åke Magnus Gisel

1977

Managing Director/CEO-

Board

NameRoleShares
D
DAIICHI SANKYO NORDICS APS
Information about the Company in the Home Country-

Others

NameRoleShares
K
KPMG ACCOUNTING AS
Accountant-
T
TMF NORWAY AS
Accountant-
Last update: Apr 13, 2023

Ownership

No available data

Financials

in NOK

Summary

Year202320222021
Total operating income
8,583,627
6,090,239
3,140,371
Annual Total Result
1,293,454
630,387
-355,441
Total assets
4,223,482
1,908,706
528,998
Total liabilities
2,284,529
1,263,206
513,885
Total equity
1,938,954
645,500
15,113

P&L

Year202320222021
Total operating income
8,583,627
6,090,239
3,140,371
Total operating costs
6,957,061
5,226,774
3,598,591
Operating result
1,626,566
863,464
-458,220
Financial income/costs
31,709
-55,219
2,528
Profit before tax
1,658,275
808,246
-455,693
Total tax & extraordinary income/cost
364,821
177,859
-100,252
Annual Total Result
1,293,454
630,387
-355,441

Balance overview

Year202320222021
Total fixed assets
0
0
100,252
Total current assets
4,223,482
1,908,706
428,746
Total assets
4,223,482
1,908,706
528,998
Short term debt
2,284,529
1,263,206
513,885
Long term debt
0
0
0
Total liabilities
2,284,529
1,263,206
513,885
Contributed capital
0
0
0
Retained earnings
1,938,954
645,500
15,113
Total equity
1,938,954
645,500
15,113
Total equity and liabilities
4,223,482
1,908,706
528,998

Classification

Category
Type of organization
Norwegian division of foreign business enterprise
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology